Large-scale testing (Phase 3)Study completedNCT02366962What this trial is testingAssess the Safety of ASP7374 in Adult Subjects Aged 20 or OlderWho this might be right forInfluenzaVaccine UMN Pharma Inc. 55
Testing effectiveness (Phase 2)Study completedNCT04969276What this trial is testingStudy of a Quadrivalent High-Dose Influenza Vaccine and a Moderna COVID-19 Vaccine Administered Either Concomitantly or Singly in Participants 65 Years of Age and Older Previously Vaccinated With a 2-dose Schedule of Moderna COVID-19 VaccineWho this might be right forInfluenza ImmunizationHealthy Volunteers Sanofi Pasteur, a Sanofi Company 306
Early research (Phase 1)Study completedNCT05426174What this trial is testingStudy to Assess the Safety and Immunogenicity of Monovalent mRNA NA Vaccine in Adult Participants 18 Years of Age and OlderWho this might be right forInfluenza ImmunizationHealthy Volunteers Sanofi Pasteur, a Sanofi Company 233
Large-scale testing (Phase 3)Study completedNCT01412281What this trial is testingImmunogenicity and Safety Study to Assess Influenza Vaccine Formulated With Haemagglutinin (HA) Antigen From Two Different SuppliersWho this might be right forInfluenza Crucell Holland BV 440
Early research (Phase 1)Study completedNCT01405885What this trial is testingDNA Vaccine With Electroporation for the Prevention of Disease Caused by H1 and H5 Influenza VirusWho this might be right forHealthy Inovio Pharmaceuticals 116
Early research (Phase 1)Study completedNCT03945825What this trial is testingFlublok or Fluzone With Advax-CpG55.2 or AF03Who this might be right forInfluenzaInfluenza Immunisation National Institute of Allergy and Infectious Diseases (NIAID) 241
Post-approval studies (Phase 4)Study completedNCT02987374What this trial is testingPilot Study in Young Adults to Examine the Kinetics of Changes in the B-cell Repertoire Following TIV ImmunizationWho this might be right forInfluenza Stanford University 10
Not applicableNot Yet RecruitingNCT07282795What this trial is testingPost-marketing Surveillance Study for the Safety of Efluelda® Pre-filled SyringeWho this might be right forInfluenza ImmunizationHealthy Volunteers Sanofi 670
Testing effectiveness (Phase 2)Study completedNCT00170547What this trial is testingComparison of Delivery Routes of Flu Vaccine in AdultsWho this might be right forInfluenza National Institute of Allergy and Infectious Diseases (NIAID) 1,597
Testing effectiveness (Phase 2)Study completedNCT00253734What this trial is testingImmunogenicity and Safety of Different Doses of Fluzone® InfluenzaWho this might be right forInfluenza National Institute of Allergy and Infectious Diseases (NIAID) 217
Testing effectiveness (Phase 2)Study completedNCT00307710What this trial is testingInfluenza Vaccination in Patients Receiving Antineoplastic Therapy for Non-Hodgkin's LymphomaWho this might be right forLymphoma M.D. Anderson Cancer Center 28
Early research (Phase 1)Study completedNCT06118151What this trial is testingSafety and Immunogenicity of a Monovalent mRNA Vaccine Encoding Influenza Hemagglutinin in Adult Participants 18 Years of Age and OlderWho this might be right forInfluenzaInfluenza Immunization Sanofi Pasteur, a Sanofi Company 388
Post-approval studies (Phase 4)Study completedNCT03028974What this trial is testingInnate and Acquired Immunity to Influenza Infection and Immunization (SLVP029)Who this might be right forInfluenza Stanford University 77
Large-scale testing (Phase 3)Study completedNCT01006187What this trial is testingComparison of Different Methods for Reducing Pain From Influenza Vaccine InjectionsWho this might be right forPainAnxiety The Hospital for Sick Children 352
Not applicableStudy completedNCT03956329What this trial is testingFlu and Mood in Older AdultsWho this might be right forVaccinationInfection University of Nottingham 654
Early research (Phase 1)Study completedNCT00812019What this trial is testingDose Ranging Study to Evaluate Immunogenicity and Safety of Adjuvanted or Non-adjuvanted Cell Culture-derived H5N1 Influenza Vaccine in Young Adults (18-40 Years Old)Who this might be right forInfluenza Seqirus 753
Not applicableStudy completedNCT02600585What this trial is testingPost-Marketing Observational Study of Safety Following Vaccination With Flublok® Compared to Licensed IIV in AdultsWho this might be right forHuman Influenza Protein Sciences Corporation 254,648
Not applicableEnded earlyNCT06062056What this trial is testingMotivational Interviewing for Vaccine Uptake in Latinx AdultsWho this might be right forVaccine Hesitancy Boston College 3,698
Post-approval studies (Phase 4)Active Not RecruitingNCT02957890What this trial is testingImmunogenicity of Twice-annual Influenza Vaccination in Older Adults in Hong KongWho this might be right forInfluenza, Human The University of Hong Kong 400
Post-approval studies (Phase 4)Study completedNCT05517174What this trial is testingA Pragmatic Randomized Trial to Evaluate the Effectiveness of High-Dose Quadrivalent Influenza Vaccine vs. Standard-Dose Quadrivalent Influenza Vaccine in Older AdultsWho this might be right forInfluenza Tor Biering-Sørensen 332,438